Ling Y - Search Results

1

[Histopathological features of squamous cell carcinoma of lung neoadjuvant immunotherapy focusing on responses].

Wei JC, Yuan P, Ling Y, Li L, Guo CY, Guo L, Xue LY, Ying JM. Wei JC, et al. Among authors: ling y. Zhonghua Bing Li Xue Za Zhi. 2021 May 8;50(5):453-457. doi: 10.3760/cma.j.cn112151-20200829-00671. Zhonghua Bing Li Xue Za Zhi. 2021. PMID: 33915650 Clinical Trial. Chinese.

2

Necrosis Is Not the Main Part of Immune-Related Pathologic Response to Neoadjuvant Immunotherapy in Squamous Cell Lung Cancer.

Li L, Ling Y, Guo C, Guo L, Ying J. Li L, et al. Among authors: ling y. J Thorac Oncol. 2021 Jan;16(1):e7-e9. doi: 10.1016/j.jtho.2020.03.032. J Thorac Oncol. 2021. PMID: 33384061 Free article. No abstract available.

3

[Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].

Ling Y, Ying JM, Qiu T, Shan L, Guo L, Lü N. Ling Y, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):590-4. doi: 10.3760/cma.j.issn.0529-5807.2012.09.004. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157825 Chinese.

4

[Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].

Qiu T, Ling Y, Chen Z, Shan L, Guo L, Lü N, Ying JM. Qiu T, et al. Among authors: ling y. Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):599-602. doi: 10.3760/cma.j.issn.0529-5807.2012.09.006. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157827 Chinese.

5

Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma.

Ying J, Guo L, Qiu T, Shan L, Ling Y, Liu X, Lu N. Ying J, et al. Among authors: ling y. Ann Oncol. 2013 Oct;24(10):2589-2593. doi: 10.1093/annonc/mdt295. Epub 2013 Jul 31. Ann Oncol. 2013. PMID: 23904459 Free article.

6

[ALK fusion gene assessment by fully automatic immunohistochemistry in non-small cell lung cancer].

Guo L, Liu X, Qiu T, Ling Y, Shan L, Xie Y. Guo L, et al. Among authors: ling y. Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):95-8. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 24742568 Chinese.

7

[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].

Zhang Z, Wu X, Ying J, Li J, Qiu T, Guo H, Zhao H, Shan L, Ling Y. Zhang Z, et al. Among authors: ling y. Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):199-205. doi: 10.3779/j.issn.1009-3419.2015.04.05. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25936883 Free PMC article. Chinese.

8

Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Li W, Zhang Z, Guo L, Qiu T, Ling Y, Cao J, Guo H, Zhao H, Li L, Ying J. Li W, et al. Among authors: ling y. Oncotarget. 2016 Feb 16;7(7):8332-40. doi: 10.18632/oncotarget.6671. Oncotarget. 2016. PMID: 26789109 Free PMC article.

9

Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma.

Wang X, Niu H, Fan Q, Lu P, Ma C, Liu W, Liu Y, Li W, Hu S, Ling Y, Guo L, Ying J, Huang J. Wang X, et al. Among authors: ling y. Oncotarget. 2016 Apr 26;7(17):24744-51. doi: 10.18632/oncotarget.8271. Oncotarget. 2016. PMID: 27013591 Free PMC article.

10

Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer.

Ling Y, Yang X, Li W, Li Z, Yang L, Qiu T, Guo L, Dong L, Li L, Ying J, Lin D. Ling Y, et al. Oncotarget. 2016 Aug 16;7(33):52862-52869. doi: 10.18632/oncotarget.10594. Oncotarget. 2016. PMID: 27418143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,388 results

Search Page

Filters